Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVEE
2851
DELISTED
NV5 Global
NVEE
| $443K | ﹤0.01% |
15,188
-24,256
| -61% | -$727K |
|
2852
US Physical Therapy
USPH
$1.18B
| $441K | ﹤0.01% |
4,039
-6,305
| -61% | -$669K |
|
2853
Preferred Bank
PFBC
$1.26B
| $440K | ﹤0.01% |
6,461
-22,383
| -78% | -$1.53M |
|
2854
Fomento Económico Mexicano
FMX
$42.4B
| $439K | ﹤0.01% |
+6,511
| New | +$482K |
|
|
MNTV
2855
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $439K | ﹤0.01% |
49,864
-27,330
| -35% | -$366K |
|
2856
First Majestic Silver
AG
$8.68B
| $438K | ﹤0.01% |
60,975
+59,484
| +3,990% | +$581K |
|
2857
Central Pacific Financial
CPF
$1.02B
| $437K | ﹤0.01% |
20,380
-36,631
| -64% | -$888K |
|
2858
PUT
Polestar Automotive Holding UK
PSNY
$2.13B
| $437K | ﹤0.01% |
+1,653
| New | +$530K |
|
|
VGR
2859
DELISTED
Vector Group Ltd.
VGR
| $437K | ﹤0.01% |
41,645
-65,142
| -61% | -$783K |
|
2860
Deluxe
DLX
$1.22B
| $436K | ﹤0.01% |
20,142
-20,098
| -50% | -$512K |
|
2861
Senseonics Holdings Inc
SENS
$282M
| $436K | ﹤0.01% |
21,150
+17,554
| +488% | +$458K |
|
2862
Tronox
TROX
$933M
| $435K | ﹤0.01% |
25,872
-13,297
| -34% | -$241K |
|
|
ARI
2863
Apollo Commercial Real Estate
ARI
$872M
| $434K | ﹤0.01% |
41,584
-65,446
| -61% | -$803K |
|
|
AZPN
2864
DELISTED
Aspen Technology Inc
AZPN
| $434K | ﹤0.01% |
+2,368
| New | +$421K |
|
2865
Bumble
BMBL
$397M
| $433K | ﹤0.01% |
15,356
+7,836
| +104% | +$213K |
|
2866
Kadant
KAI
$3.98B
| $433K | ﹤0.01% |
2,376
-730
| -24% | -$136K |
|
|
AONC
2867
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $433K | ﹤0.01% |
44,321
| – | – |
|
|
MCBC
2868
DELISTED
Macatawa Bank Corp
MCBC
| $432K | ﹤0.01% |
48,836
-6,761
| -12% | -$60.4K |
|
2869
Agios Pharmaceuticals
AGIO
$1.89B
| $431K | ﹤0.01% |
19,420
-46,460
| -71% | -$1.05M |
|
|
ADAP
2870
DELISTED
Adaptimmune Therapeutics
ADAP
| $430K | ﹤0.01% |
+252,682
| New | +$434K |
|
2871
Dycom Industries
DY
$12.3B
| $429K | ﹤0.01% |
4,610
-4,435
| -49% | -$395K |
|
|
HTZWW
2872
Hertz Global Holdings Warrants
HTZWW
$67.7M
| $428K | ﹤0.01% |
43,737
| – | – |
|
|
SGMO
2873
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $428K | ﹤0.01% |
103,306
+38,773
| +60% | +$168K |
|
2874
Carpenter Technology
CRS
$28.3B
| $427K | ﹤0.01% |
15,289
-23,217
| -60% | -$826K |
|
2875
Gevo
GEVO
$372M
| $427K | ﹤0.01% |
+181,601
| New | +$664K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.